Northern Trust’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Sell |
995,305
-94,153
| -9% | -$227K | ﹤0.01% | 2885 |
|
|
2025
Q1 | $2.41M | Buy |
1,089,458
+19,033
| +2% | +$42.1K | ﹤0.01% | 2822 |
|
|
2024
Q4 | $5.83M | Buy |
1,070,425
+53,474
| +5% | +$291K | ﹤0.01% | 2417 |
|
|
2024
Q3 | $8.45M | Buy |
1,016,951
+89,395
| +10% | +$743K | ﹤0.01% | 2161 |
|
|
2024
Q2 | $6.64M | Sell |
927,556
-23,756
| -2% | -$170K | ﹤0.01% | 2236 |
|
|
2024
Q1 | $8.25M | Buy |
951,312
+5,330
| +0.6% | +$46.2K | ﹤0.01% | 2169 |
|
|
2023
Q4 | $6.2M | Sell |
945,982
-44,222
| -4% | -$290K | ﹤0.01% | 2375 |
|
|
2023
Q3 | $9.9M | Buy |
990,204
+424,568
| +75% | +$4.25M | ﹤0.01% | 2014 |
|
|
2023
Q2 | $7.03M | Sell |
565,636
-255,251
| -31% | -$3.17M | ﹤0.01% | 2298 |
|
|
2023
Q1 | $11.5M | Buy |
820,887
+23,611
| +3% | +$331K | ﹤0.01% | 1920 |
|
|
2022
Q4 | $11.4M | Buy |
797,276
+276,055
| +53% | +$3.95M | ﹤0.01% | 1917 |
|
|
2022
Q3 | $13.3M | Buy |
521,221
+55,792
| +12% | +$1.42M | ﹤0.01% | 1780 |
|
|
2022
Q2 | $13.2M | Sell |
465,429
-21,578
| -4% | -$613K | ﹤0.01% | 1819 |
|
|
2022
Q1 | $17.2M | Buy |
487,007
+91
| +0% | +$3.21K | ﹤0.01% | 1780 |
|
|
2021
Q4 | $20.4M | Buy |
486,916
+18,840
| +4% | +$789K | ﹤0.01% | 1756 |
|
|
2021
Q3 | $23M | Sell |
468,076
-237,310
| -34% | -$11.6M | ﹤0.01% | 1699 |
|
|
2021
Q2 | $29.4M | Buy |
705,386
+359,390
| +104% | +$15M | 0.01% | 1610 |
|
|
2021
Q1 | $12.3M | Buy |
+345,996
| New | +$12.3M | ﹤0.01% | 2158 |
|